-
1دورية أكاديمية
المؤلفون: Hung CF; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland.; 2 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, Maryland., Xu X; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland., Li L; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Ma Y; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland., Jin Q; 1 Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, Maryland., Viley A; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Allen C; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Natarajan P; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Shivakumar R; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Peshwa MV; 3 MaxCyte, Inc. , Gaithersburg, Maryland., Emens LA; 2 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, Maryland.; 4 Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy , Baltimore, Maryland.
المصدر: Human gene therapy [Hum Gene Ther] 2018 May; Vol. 29 (5), pp. 614-625. Date of Electronic Publication: 2018 Apr 02.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: M.A. Liebert Country of Publication: United States NLM ID: 9008950 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7422 (Electronic) Linking ISSN: 10430342 NLM ISO Abbreviation: Hum Gene Ther Subsets: MEDLINE
مواضيع طبية MeSH: GPI-Linked Proteins/*immunology , Natural Killer T-Cells/*transplantation , Ovarian Neoplasms/*therapy , Receptors, Antigen, T-Cell/*therapeutic use, Animals ; Cell Line, Tumor ; Female ; GPI-Linked Proteins/antagonists & inhibitors ; GPI-Linked Proteins/therapeutic use ; Humans ; Immunotherapy, Adoptive ; Lymphocytes/immunology ; Mesothelin ; Mice ; Natural Killer T-Cells/immunology ; Ovarian Neoplasms/immunology ; RNA, Messenger/genetics ; RNA, Messenger/therapeutic use ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/therapeutic use ; Xenograft Model Antitumor Assays